Live Quote · NASDAQINCRHealthcare· Drug Manufacturers - Specialty & Generic

InterCure Ltd.

$1.09 3.54%($-0.04)
TickerSpark Score
66/100
Solid
80
Valuation
30
Profitability
90
Growth
48
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INCR research report →

52-Week Range38% of range
Low
$0.68
Current
$1.09
High
$1.77
Company Overviewwww.intercure.co

About the company

InterCure Ltd. , including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories.

CEO
Alexander Rabinovich
IPO
2019
Employees
320
HQ
Herzliya, IL

Price Chart

-26.35% · this period
$1.73$1.23$0.73Jul 02Dec 31Jul 02
Valuation
Market Cap
$62.30M
P/E
-3.96
P/S
1.00
P/B
0.47
EV/EBITDA
-9.94
Div Yield
0.00%
Profitability
Gross Margin
21.66%
Op Margin
-17.77%
Net Margin
-19.47%
ROE
-8.77%
ROIC
-4.79%
Growth & Income
Revenue
$270.20M · 13.13%
Net Income
$-35,710,000 · 47.33%
EPS
$-0.63 · 55.63%
Op Income
$6.73M
FCF YoY
118.64%
Performance & Tape
52W High
$1.77
52W Low
$0.68
50D MA
$0.93
200D MA
$1.08
Beta
0.57
Avg Volume
56.11K

Get TickerSpark's AI analysis on INCR

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 18, 26Michelson Lennie Grinbaumother0
Mar 31, 20Michelson Lennie Grinbaumother4,406
Sep 30, 24Michelson Lennie Grinbaumother15,000
Sep 30, 24Granot Alon Shmuelother15,000
Mar 18, 26Rabinovich Alexanderother0
Mar 18, 26Rabinovich Alexanderother0
Mar 18, 26Rabinovich Alexanderother0
Mar 18, 26Rabinovich Alexanderother0
Mar 3, 25Rabinovich Alexanderother2,070,393
Sep 15, 22Rabinovich Alexanderother460,000
Coverage · INCR

Our INCR coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on INCR yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate INCR report →
Internal Compare

Similar companies

Peers in the same neighborhood.